Journal article
Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection
The Journal of experimental medicine, Vol.212(11), pp.1851-1868
10/19/2015
DOI: 10.1084/jem.20150632
PMCID: PMC4612096
PMID: 26392224
Abstract
Oxidative stress and chronic low-grade inflammation in the lungs are associated with aging and may contribute to age-related immune dysfunction. To maintain lung homeostasis, chronic inflammation is countered by enhanced expression of proresolving/antiinflammatory factors. Here, we show that age-dependent increases of one such factor in the lungs, a phospholipase A2 (PLA2) group IID (PLA2G2D) with antiinflammatory properties, contributed to worse outcomes in mice infected with severe acute respiratory syndrome-coronavirus (SARS-CoV). Strikingly, infection of mice lacking PLA2G2D expression (Pla2g2d(-/-) mice) converted a uniformly lethal infection to a nonlethal one (>80% survival), subsequent to development of enhanced respiratory DC migration to the draining lymph nodes, augmented antivirus T cell responses, and diminished lung damage. We also observed similar effects in influenza A virus-infected middle-aged Pla2g2d(-/-) mice. Furthermore, oxidative stress, probably via lipid peroxidation, was found to induce PLA2G2D expression in mice and in human monocyte-derived macrophages. Thus, our results suggest that directed inhibition of a single inducible phospholipase, PLA2G2D, in the lungs of older patients with severe respiratory infections is potentially an attractive therapeutic intervention to restore immune function.
Details
- Title: Subtitle
- Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection
- Creators
- Rahul Vijay - Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242Xiaoyang Hua - Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242David K Meyerholz - Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242Yoshimi Miki - Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, JapanKei Yamamoto - Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, JapanMichael Gelb - Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195 Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195Makoto Murakami - Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama 332-0012, JapanStanley Perlman - Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Stanley-Perlman@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- The Journal of experimental medicine, Vol.212(11), pp.1851-1868
- DOI
- 10.1084/jem.20150632
- PMID
- 26392224
- PMCID
- PMC4612096
- NLM abbreviation
- J Exp Med
- ISSN
- 0022-1007
- eISSN
- 1540-9538
- Publisher
- United States
- Grant note
- AI091322 / NIAID NIH HHS R01 HL036235 / NHLBI NIH HHS AI060699 / NIAID NIH HHS R37 HL036235 / NHLBI NIH HHS HL36235 / NHLBI NIH HHS R01 AI091322 / NIAID NIH HHS P01 AI060699 / NIAID NIH HHS P30 DK054759 / NIDDK NIH HHS
- Language
- English
- Date published
- 10/19/2015
- Academic Unit
- Microbiology and Immunology; Stead Family Department of Pediatrics; Pathology; Iowa Neuroscience Institute; Otolaryngology; Infectious Disease (Pediatrics)
- Record Identifier
- 9983777353602771
Metrics
33 Record Views